Immix Biopharma Analyst Ratings
Immix Biopharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/22/2023 | 566.67% | Roth MKM | → $14 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 02/22/2023 | 566.67% | 罗斯MKM | →$14 | 开始承保 | →购买 |
What is the target price for Immix Biopharma (IMMX)?
ImMix Biophma(IMMX)的目标价格是多少？
The latest price target for Immix Biopharma (NASDAQ: IMMX) was reported by Roth MKM on February 22, 2023. The analyst firm set a price target for $14.00 expecting IMMX to rise to within 12 months (a possible 566.67% upside). 1 analyst firms have reported ratings in the last year.
Roth MKM于2023年2月22日报道了ImMix Biophma(纳斯达克：IMMX)的最新目标价。这家分析公司将目标价定为14美元，预计IMMX将在12个月内上涨至(可能上涨566.67%)。1家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Immix Biopharma (IMMX)?
ImMix Biophma(IMMX)的最新分析师评级是多少？
The latest analyst rating for Immix Biopharma (NASDAQ: IMMX) was provided by Roth MKM, and Immix Biopharma initiated their buy rating.
Roth MKM对ImMix Biophma(纳斯达克代码：IMMX)的最新分析师评级是由Roth MKM提供的，ImMix Biophma启动了他们的买入评级。
When is the next analyst rating going to be posted or updated for Immix Biopharma (IMMX)?
IMMIX Biophma(IMMX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immix Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immix Biopharma was filed on February 22, 2023 so you should expect the next rating to be made available sometime around February 22, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与ImMix Biophma的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。ImMix Biophma的最后一次评级是在2023年2月22日提交的，所以你应该预计下一次评级将在2024年2月22日左右的某个时候提供。
Is the Analyst Rating Immix Biopharma (IMMX) correct?
分析师对IMMIX Biophma(IMMX)的评级正确吗？
While ratings are subjective and will change, the latest Immix Biopharma (IMMX) rating was a initiated with a price target of $0.00 to $14.00. The current price Immix Biopharma (IMMX) is trading at is $2.10, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的IMMIX Biophma(IMMX)评级是以0.00美元至14.00美元的目标价启动的。ImMix Biophma(IMMX)目前的交易价格为2.10美元，在分析师的预测范围内。